FDA Import Refusal AEK-3046284-7/121/1 — Eisai, Inc.
The FDA refused shipment AEK-3046284-7/121/1 from Eisai, Inc. (United States) on Mar 21, 2017. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Mar 21, 2017
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 60SDA27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75